Iota Biosciences, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2018 | $15 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Iota Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).
SEC Form D · May 2018
The industry group it chose in its notices: Other Technology.
SEC Form D · May 2018
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Iota Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jose Carmena | Executive officer | May 2018 |
| Michel Maharbiz | Executive officer | May 2018 |
| Jose Carmena | Director | May 2018 |
| Michel Maharbiz | Director | May 2018 |
| Patrick Zhang | Director | May 2018 |